A Study of CN1 in Combination With CN401 in Adult Patients With Relapsed/Refractory Lymphoid Malignancies
Status:
Recruiting
Trial end date:
2023-07-30
Target enrollment:
Participant gender:
Summary
The study is designed to investigate the safety, tolerability and preliminary efficacy in
combination with CN1 and CN401 in adult patients with relapsed/refractory lymphoid
malignancies.